EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Galectin-3 and incident heart failure among patients with pre-existing coronary artery disease: The ADVANCE study

Carlos Iribarren, Malini Chandra, Jamal S. Rana, Mark A. Hlatky, Stephen P. Fortmann, Thomas Quertermous, Alan S. Go

Clinical Trials and Regulatory Science in Cardiology · 2015

DOI: 10.1016/j.ctrsc.2015.08.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2015. Verfasst von Carlos Iribarren und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Iribarren, C., Chandra, M., Rana, J. S., Hlatky, M. A., Fortmann, S. P., Quertermous, T., & Go, A. S. (2015). Galectin-3 and incident heart failure among patients with pre-existing coronary artery disease: The ADVANCE study. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.08.002

Vancouver

Iribarren C, Chandra M, Rana JS, Hlatky MA, Fortmann SP, Quertermous T, et al. Galectin-3 and incident heart failure among patients with pre-existing coronary artery disease: The ADVANCE study. Clinical Trials and Regulatory Science in Cardiology. 2015. doi:10.1016/j.ctrsc.2015.08.002

BibTeX
@article{Iribarren2015,
  author = {Iribarren, Carlos and Chandra, Malini and Rana, Jamal S. and Hlatky, Mark A. and Fortmann, Stephen P. and Quertermous, Thomas and Go, Alan S.},
  title = {Galectin-3 and incident heart failure among patients with pre-existing coronary artery disease: The ADVANCE study},
  journal = {Clinical Trials and Regulatory Science in Cardiology},
  year = {2015},
  doi = {10.1016/j.ctrsc.2015.08.002}
}
Kostenlos starten →